Trial Profile
Phase I study of a combination of capecitabine plus CPT-11 (CC therapy) in patients with metastatic colon cancer refractory to oxaliplatin containing chemotherapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2017
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Capecitabine
- Indications Colon cancer
- Focus Adverse reactions
- 21 Feb 2017 Status changed from recruiting to completed.
- 13 May 2016 New trial record